Literature DB >> 32229546

HBV vaccination and HBV infection induces HBV-specific natural killer cell memory.

Ratna S Wijaya1,2, Scott A Read1,3,4, Naomi R Truong5, Shuanglin Han1, Dishen Chen1,3, Haleh Shahidipour1,3,4, Nicole L Fewings6, Stephen Schibeci6, Mahmoud K Azardaryany1, Grant P Parnell6, David Booth6, David van der Poorten7, Rita Lin7, Jacob George1,7, Mark W Douglas1,7,8, Golo Ahlenstiel9,3,4.   

Abstract

OBJECTIVE: Vaccination against hepatitis B virus (HBV) confers protection from subsequent infection through immunological memory that is traditionally considered the domain of the adaptive immune system. This view has been challenged following the identification of antigen-specific memory natural killer cells (mNKs) in mice and non-human primates. While the presence of mNKs has been suggested in humans based on the expansion of NK cells following pathogen exposure, evidence regarding antigen-specificity is lacking. Here, we demonstrate the existence of HBV-specific mNKs in humans after vaccination and in chronic HBV infection.
DESIGN: NK cell responses were evaluated by flow cytometry and ELISA following challenge with HBV antigens in HBV vaccinated, non-vaccinated and chronic HBV-infected individuals.
RESULTS: NK cells from vaccinated subjects demonstrated higher cytotoxic and proliferative responses against autologous hepatitis B surface antigen (HBsAg)-pulsed monocyte-derived dendritic cells (moDCs) compared with unvaccinated subjects. Moreover, NK cell lysis of HBsAg-pulsed moDCs was significantly higher than that of hepatitis B core antigen (HBcAg)-pulsed moDCs (non-vaccine antigen) or tumour necrosis factor α-activated moDCs in a NKG2D-dependent manner. The mNKs response was mediated by CD56dim NK cells coexpressing CD57, CD69 and KLRG1. Further, mNKs from chronic hepatitis B patients exhibited greater degranulation against HBcAg-pulsed moDCs compared with unvaccinated or vaccinated patients. Notably, mNK activity was negatively correlated with HBV DNA levels.
CONCLUSIONS: Our data support the presence of a mature mNKs following HBV antigen exposure either through vaccination or infection. Harnessing these antigen specific, functionally active mNKs provides an opportunity to develop novel treatments targeting HBV in chronic infection. © Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  cellular immunity; chronic viral hepatitis; hepatitis B; immune response

Year:  2020        PMID: 32229546     DOI: 10.1136/gutjnl-2019-319252

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  10 in total

Review 1.  Human Innate Lymphoid Cells in Influenza Infection and Vaccination.

Authors:  Amrita Kumar; Rashmi Kumari; Timothy Liu; Weiping Cao; Bruce A Davidson; Paul R Knight; Suryaprakash Sambhara
Journal:  Crit Rev Immunol       Date:  2021       Impact factor: 1.735

Review 2.  Learning to Be Elite: Lessons From HIV-1 Controllers and Animal Models on Trained Innate Immunity and Virus Suppression.

Authors:  Sho Sugawara; R Keith Reeves; Stephanie Jost
Journal:  Front Immunol       Date:  2022-04-27       Impact factor: 8.786

3.  Highly multiplexed 2-dimensional imaging mass cytometry analysis of HBV-infected liver.

Authors:  Daniel Traum; Yue J Wang; Kathleen B Schwarz; Jonathan Schug; David Kh Wong; Harry LA Janssen; Norah A Terrault; Mandana Khalili; Abdus S Wahed; Karen F Murray; Phillip Rosenthal; Simon C Ling; Norberto Rodriguez-Baez; Richard K Sterling; Daryl Ty Lau; Timothy M Block; Michael D Feldman; Elizabeth E Furth; William M Lee; David E Kleiner; Anna S Lok; Klaus H Kaestner; Kyong-Mi Chang
Journal:  JCI Insight       Date:  2021-04-08

Review 4.  Targeting natural killer cells to enhance vaccine responses.

Authors:  Andrew Cox; Hilal Cevik; H Alex Feldman; Laura M Canaday; Nora Lakes; Stephen N Waggoner
Journal:  Trends Pharmacol Sci       Date:  2021-07-23       Impact factor: 17.638

Review 5.  Targeting Natural Killer Cells for Improved Immunity and Control of the Adaptive Immune Response.

Authors:  Stephen Pierce; Eric S Geanes; Todd Bradley
Journal:  Front Cell Infect Microbiol       Date:  2020-05-19       Impact factor: 5.293

Review 6.  NK Cell-Mediated Recall Responses: Memory-Like, Adaptive, or Antigen-Specific?

Authors:  Victoria Stary; Georg Stary
Journal:  Front Cell Infect Microbiol       Date:  2020-05-14       Impact factor: 5.293

Review 7.  Regulation of the human NK cell compartment by pathogens and vaccines.

Authors:  Martin R Goodier; Eleanor M Riley
Journal:  Clin Transl Immunology       Date:  2021-01-18

8.  NK cell frequencies, function and correlates to vaccine outcome in BNT162b2 mRNA anti-SARS-CoV-2 vaccinated healthy and immunocompromised individuals.

Authors:  Caroline Boulouis; Iva Filipovic; David Wullimann; Angelica Cuapio; Tobias Kammann; Tiphaine Parrot; Puran Chen; Mira Akber; Yu Gao; Quirin Hammer; Benedikt Strunz; André Pérez Potti; Olga Rivera Ballesteros; Joshua Lange; Jagadeeswara Rao Muvva; Peter Bergman; Ola Blennow; Lotta Hansson; Stephan Mielke; Piotr Nowak; Gunnar Söderdahl; Anders Österborg; C I Edvard Smith; Gordana Bogdanovic; Sandra Muschiol; Fredrika Hellgren; Karin Loré; Michal J Sobkowiak; Giorgio Gabarrini; Katie Healy; Margaret Sällberg Chen; Evren Alici; Niklas K Björkström; Marcus Buggert; Per Ljungman; Johan K Sandberg; Soo Aleman; Hans-Gustaf Ljunggren
Journal:  Mol Med       Date:  2022-02-08       Impact factor: 6.354

Review 9.  Natural killer cells in antiviral immunity.

Authors:  Niklas K Björkström; Benedikt Strunz; Hans-Gustaf Ljunggren
Journal:  Nat Rev Immunol       Date:  2021-06-11       Impact factor: 53.106

Review 10.  Immunomodulation of the Natural Killer Cell Phenotype and Response during HCV Infection.

Authors:  Gaitan Fabrice Njiomegnie; Scott A Read; Nicole Fewings; Jacob George; Fiona McKay; Golo Ahlenstiel
Journal:  J Clin Med       Date:  2020-04-06       Impact factor: 4.241

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.